PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

$77.9M

Market Cap • 12/20/2024

2013

(11 years)
Founded

2020

(4 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Princeton

Headquarters • New Jersey

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions
  • ...and much more!

    Get Premium